Book Reviews

March 2001 in “ International Journal of Cosmetic Surgery and Aesthetic Dermatology ”

Alan B. Brackup

cosmetic surgery dermatology cosmetology consumer health protection cosmetic claims scarless wound healing biochemistry of scarring wound repair keloid formation skin substitutes cosmeceuticals adverse reactions plastic surgery aesthetic surgery cosmetic surgery dermatology cosmetology consumer health protection cosmetic claims scarless wound healing scarring wound repair keloid skin substitutes cosmeceuticals adverse reactions plastic surgery aesthetic surgery

Studysummary This article is a collection of book reviews in the International Journal of Cosmetic Surgery and Aesthetic Dermatology and presents no new clinical findings.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on liebertpub.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community New topical claims complete reversal of AGA in 3 months

18 upvotes 9 years ago

A new topical treatment called RT1640 claims to reverse AGA using cyclosporine A, Minoxidil, and a new chemical entity, RT175. Users are skeptical due to lack of clinical trial data and inconsistent before-and-after photos.

community Curious on your thoughts on this article i stumbled upon.

5 upvotes 4 years ago

Concerns about dermarolling potentially causing collagen breakdown and cancer, with skepticism about the claims due to lack of scientific evidence. Users express doubts and discuss the validity of the article's claims.

community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

118 upvotes 2 years ago

Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

community Post TCA pic and two month in, just posting baseline and an update.

6 upvotes 7 months ago

The conversation is about a user's hair loss treatment regimen, which includes Dutasteride, oral Minoxidil, topical Dutasteride, Minoxidil sulfate, antioxidants, and various supplements. The user is also using a derma stamp and has paused Tretinoin due to a TCA peel recovery.

community I just came across an ad for a product that I'd never seen called HairMDL.

2 upvotes 5 months ago

A product called HairMDL includes Minoxidil, Dutasteride, Latanoprost, caffeine, Tretinoin, and Triamcinolone. Users are curious about its effectiveness and safety, particularly regarding the topical steroid Triamcinolone.

community Breezula Phase III 12-Month Data Released by Cosmo Pharma

42 upvotes 5 months ago

Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.